IP Verse

Combination Products With Tyrosine Kinase Inhibitors And Their Use

Patent No. EP2834246 (titled "Combination Products With Tyrosine Kinase Inhibitors And Their Use") was filed by Novartis on Apr 3, 2013. The application was issued on Jul 28, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
D YOUNGApr 28, 2022D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2834246

NOVARTIS
Application Number
EP13772621A
Filing Date
Apr 3, 2013
Status
Revoked
Jul 21, 2023
Publication Date
Jul 28, 2021
External Links
Slate, Register , Google Patents